Raghuram Selvaraju

Raghuram Selvaraju, PhD, MBA, currently serves as the Managing Director of Healthcare Equity Research at H.C. Wainwright & Co., LLC, where responsibilities include leading the healthcare equity research initiative and developing the life sciences platform with a focus on biotechnology and related fields. In parallel, Raghuram holds the position of Chairman of the Board of Directors at RELIEF THERAPEUTICS Holding AG, overseeing strategic initiatives for the biopharmaceutical company. With extensive experience at various financial institutions including MLV & Co, Aegis Capital, and Morgan Joseph TriArtisan Group, Raghuram has developed a strong background in equity research, particularly in biotechnology and life sciences. Educational credentials include an MBA from Cornell University and a PhD in Biochemistry from the University of Geneva.